Beta-Blocker Use and Health Status Among Patients With Heart Failure With Preserved Ejection Fraction
1. In patients with heart failure with preserved ejection fraction (HFpEF), Beta-blocker use was not associated with concurrent baseline health ...
1. In patients with heart failure with preserved ejection fraction (HFpEF), Beta-blocker use was not associated with concurrent baseline health ...
β-Blocker Use and Health Status Among Patients With Heart Failure With Preserved Ejection Fraction 1. In patients with heart failure ...
1. In this systematic review and meta-analysis, there were no significant differences between various pharmacologic treatments for preventing episodic migraine ...
1. In this randomized controlled trial, among patients with a history of myocardial infarction (MI), interruption of long-term beta-blocker therapy ...
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Click to read the study in NEJM ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
1. In this randomized controlled trial, long-term beta-blockers did not impact all-cause mortality among patients with preserved left ventricular ejection ...
1. A significant reduction in all-cause mortality was seen among patients in the intervention group compared to usual care. 2. ...
1. Amongst a cohort of individuals with arterial hypertension, those who were taking angiotensin receptor blocker antihypertensives had the lowest ...
1. Compared to control, ARBs reduced the annual rate of increase of the aortic root Z score by approximately one-half. ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.